Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4868309
Max Phase: Preclinical
Molecular Formula: C46H47ClF3N5O7
Molecular Weight: 874.36
Molecule Type: Unknown
Associated Items:
ID: ALA4868309
Max Phase: Preclinical
Molecular Formula: C46H47ClF3N5O7
Molecular Weight: 874.36
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOC(=O)c1[nH]c2cc(Cl)ccc2c1C(C(=O)NC(C)(C)C)N(Cc1cc(F)c(F)c(F)c1)C(=O)CCCCCCC#Cc1cccc2c1CN(C1CCC(=O)NC1=O)C2=O
Standard InChI: InChI=1S/C46H47ClF3N5O7/c1-5-62-45(61)40-38(30-18-17-28(47)23-34(30)51-40)41(43(59)53-46(2,3)4)55(24-26-21-32(48)39(50)33(49)22-26)37(57)16-11-9-7-6-8-10-13-27-14-12-15-29-31(27)25-54(44(29)60)35-19-20-36(56)52-42(35)58/h12,14-15,17-18,21-23,35,41,51H,5-9,11,16,19-20,24-25H2,1-4H3,(H,53,59)(H,52,56,58)
Standard InChI Key: MFUGREJDISQKLY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 874.36 | Molecular Weight (Monoisotopic): 873.3116 | AlogP: 7.55 | #Rotatable Bonds: 14 |
Polar Surface Area: 157.98 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.31 | CX Basic pKa: | CX LogP: 7.12 | CX LogD: 7.12 |
Aromatic Rings: 4 | Heavy Atoms: 62 | QED Weighted: 0.04 | Np Likeness Score: -0.80 |
1. Wang B, Liu J, Tandon I, Wu S, Teng P, Liao J, Tang W.. (2021) Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries., 219 [PMID:33862513] [10.1016/j.ejmech.2021.113425] |
Source(1):